CYP3A Polymorphism and Chronic Mercury Intoxication

被引:3
|
作者
Chernyak, Yu. I. [1 ]
Merinova, A. P. [1 ]
机构
[1] East Siberian Inst Med & Ecol Res, Angarsk, Russia
关键词
mercury; chronic mercury intoxication; cytochrome P4503A (CYP3A); genetic polymorphism; antipyrine metabolism; METHYLMERCURY; METABOLISM; GENES;
D O I
10.1007/s10517-020-04738-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We analyzed the relationship between polymorphic loci of CYP3A genes (CYP3A4 (rs2740574), CYP3A5 (rs776746) and CYP3A7 (rs2257401)) with the development of chronic mercury intoxication. Of 170 men examined, 120 were workers chronically exposed to mercury vapors and 50 were carriers of GG-HSPA1B (+1267A/G) genotype associated with chronic mercury intoxication. Urinary content of 4-hydroxyantipyrine (4-HAP) generated in the reaction predominantly catalyzed by CYP3A4/CYP3A5 was studied in workers without chronic mercury intoxication (group 1, N=46) and patients in the delayed period of chronic mercury intoxication (group 2, N=74) depending on the genotypes of CYP3A4 and CYP3A5. For polymorphic loci CYP3A5 and CYP3A7, a tendency to an increase in the frequency of genotypes with rare alleles was found (p=0.071 and p=0.078) in the combined group (group 2 together with GGHSPA1B genotype carriers) relative to group 1. The high level of linkage disequilibrium was noted, especially for the pair rs776746 and rs2257401 (LD (r)=0.89). In group 2, a trend to 4-HAP decrease compared to group 1 (p=0.056 and p=0.065) was revealed for carriers of AA-CYP3A4 and GG-CYP3A5 genotypes. The involvement of CYP3A in the development of mercury neurotoxic effect remains unclear.
引用
收藏
页码:492 / 495
页数:4
相关论文
共 50 条
  • [21] Genomic organization of the human CYP3A locus:: identification of a new, inducible CYP3A gene
    Gellner, K
    Eiselt, R
    Hustert, E
    Arnold, H
    Koch, I
    Haberl, M
    Deglmann, CJ
    Burk, O
    Buntefuss, D
    Escher, S
    Bishop, C
    Koebe, HG
    Brinkmann, U
    Klenk, HP
    Kleine, K
    Meyer, UA
    Wojnowski, L
    PHARMACOGENETICS, 2001, 11 (02): : 111 - 121
  • [22] Unusually high serum levels of clozapine associated with genetic polymorphism of CYP3A enzymes
    John, Alexander Panickacheril
    Kecanovic, Alma
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 57
  • [23] DIRECT N-GLUCURONIDATION OF THE CYP3A PROBE MIDAZOLAM: EFFECTS OF A CYP3A AND DUAL CYP3A/UGT1A4 INHIBITOR IN HEALTHY VOLUNTEERS
    Dua, R.
    Gonzalez-Perez, V.
    Frederick, K. S.
    Denton, C. L.
    Scarlett, Y. V.
    Fisher, M. B.
    Paine, M. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S11 - S11
  • [24] Evaluation of drug interaction potential of CYP3A substrates - a tailored approach based on FM,CYP3A
    Sato, Masanobu
    Liu, Qi
    Yoshida, Kenta
    Li, Li
    Rekic, Dinko
    Reynolds, Kellie
    Zhang, Lei
    Huang, Shiew Mei
    Sinha, Vikram
    Zhao, Ping
    DRUG METABOLISM REVIEWS, 2016, 48 : 70 - 71
  • [25] Identification of a CYP3A form (CYP3A126) in fathead minnow (Pimephales promelas) and characterisation of putative CYP3A enzyme activity
    Christen, Verena
    Caminada, Daniel
    Arand, Michael
    Fent, Karl
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2010, 396 (02) : 585 - 595
  • [26] Induction of CYP3A by morroniside in rats
    Xiong, Shan
    Li, Jinglai
    Zhang, Wenpeng
    Wang, Xiaoying
    Zhang, Zhenqing
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (04) : 414 - 418
  • [27] A map of the mouse Cyp3a locus
    Zaphiropoulos, PG
    DNA SEQUENCE, 2003, 14 (03): : 155 - 162
  • [28] CYP3A genetics in drug metabolism
    Eichelbaum, M
    Burk, O
    NATURE MEDICINE, 2001, 7 (03) : 285 - 287
  • [29] NONINVASIVE TESTS OF CYP3A ENZYMES
    WATKINS, PB
    PHARMACOGENETICS, 1994, 4 (04): : 171 - 184
  • [30] Identification of a CYP3A form (CYP3A126) in fathead minnow (Pimephales promelas) and characterisation of putative CYP3A enzyme activity
    Verena Christen
    Daniel Caminada
    Michael Arand
    Karl Fent
    Analytical and Bioanalytical Chemistry, 2010, 396 : 585 - 595